|
|
Volumn 334, Issue 17, 1996, Pages 1126-1128
|
|
Platelets and coronary artery disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
HEPARIN;
PHENPROCOUMON;
TICLOPIDINE;
ARTERY THROMBOSIS;
BONE MARROW APLASIA;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
EDITORIAL;
GASTROINTESTINAL HEMORRHAGE;
GENETIC POLYMORPHISM;
HEART INFARCTION;
HUMAN;
INTRAHEPATIC CHOLESTASIS;
NEUTROPENIA;
PRIORITY JOURNAL;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNSTABLE ANGINA PECTORIS;
VEIN THROMBOSIS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICOAGULANTS;
CORONARY DISEASE;
DRUG THERAPY, COMBINATION;
HEPARIN;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
POLYMORPHISM, GENETIC;
STENTS;
TICLOPIDINE;
|
|
EID: 0029988640
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199604253341710 Document Type: Editorial |
|
Times cited : (41)
|
|
References (0)
|
